PROVIDER PROFILE · NPI 1306077755
Mark MintunPA-C
PRESCRIBING · PART D · 2024
Total Rx claims
51
Beneficiaries
—
Total drug cost
$392
Distinct drugs
3
Brand share
33.3%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
80.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
CROSS-REFERENCE